The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.

The Chemo Concession Persists - Part II

mono5
mono5 CSN Member Posts: 94
edited March 2014 in Lung Cancer #1
The authors chose to focus on lung cancer because of the various treatment options, some of which are considerably more expensive than others. They found that doctors frequently switched drugs to choose the more expensive options. There was, for instance, an increased use of docetaxel (Taxotere), a drug for which oncologist get reimbursed about $2,500 per patient per month. http://www.cancerdecisions.com/content/view/526/2/lang,english/ Part 2
http://www.cancerdecisions.com/content/view/525/2/lang,english/ Part 1
Like Care

Comments

Discussion Boards